Skip to content
Search AI Powered

Latest Stories

CPE asks for ‘inputs’ on winter pressure from independents and non-CCA

Community pharmacy owners to share their views in the new survey

Community Pharmacy England (CPE) is seeking views from all community pharmacy owners about the pressures faced this autumn season.


A survey has been launched as the “November Pre-Committee Opinion Poll” until 6 November to seek views from independents and non-Company Chemists’ Association (CCA) members.

The results of the poll will be sent to the head offices of CCA multiples next week for discussion at the November Committee Meeting.

CPE confirmed: "The results of these polls and the outcomes of the meeting will be reported back to the sector afterwards.

They said that the survey "will be used to feed into our ongoing work to press for an uplift to core funding by enhancing our evidence base of what pharmacy owners are experiencing."

"This and future surveys will also increase the amount of data we have for use in our campaigning and influencing work,” CPE added.

The Committee meeting will discuss progress in negotiations, focusing on the 2024-2025 Community Pharmacy Contractual Framework (CPCF) and the future strategy for Community Pharmacy England.

It is guided by the recently published Vision for Community Pharmacy report by The King's Fund and the Nuffield Trust.

“This new approach to engagement aims to help us to build stronger relationships with pharmacy owners by improving how we engage with the sector and listening to pharmacy’s views better,” CPE further added.

The community pharmacies have been facing unsustainable pressures through the autumn period.

In the statement, CPE also assures that they are also tracking the financial pressures on community pharmacies.

More For You

New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
It is official: Opella is now a standalone company

Opella launches as an independent company to redefine the future of self-care.

Photo credit: gettyimages

Opella becomes standalone company as Sanofi-CD&R deal closes

Opella has officially become a standalone company, following the completion of Sanofi’s sale of a controlling 50.0% stake to private equity firm Clayton, Dubilier & Rice (CD&R).

Sanofi retains a significant shareholding with a 48.2% stake while Bpifrance holds the remaining 1.8% stake.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less